Literature DB >> 2504014

Evaluation of a phenolglycolipid antigen (PGL-Tb 1) from M. tuberculosis in the serodiagnosis of tuberculosis: comparison with PPD antigen.

N Martín Casabona1, T Gonzalez Fuente, L Arcalis Arce, J Otal Entraigas, R Vidal Pla.   

Abstract

Sera from 38 tuberculous patients and 62 healthy controls (31 PPD skin test positive and 31 negative) were assayed, by enzyme-linked immunosorbent assay (ELISA), to test the activity of IgG and IgM antibodies against purified protein derivative (PPD) antigen and a phenolglycolipid antigen (PLG-Tb 1) isolated and purified from Mycobacterium tuberculosis strain Canetti. Using PPD antigen, the sensitivity and specificity were respectively, 50 and 93.5% for IgG and 71.1 and 59.7% for IgM antibody activity. Against PGL-Tb 1 antigen, IgG had a sensitivity of 94.7% and the specificity was 96.8%, for IgM antibody they were 65.8% and 75.8% respectively. The ELISA using PGL-Tb 1 antigen could be a useful way to develop a rapid technique to aid in the diagnosis of tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504014

Source DB:  PubMed          Journal:  Acta Leprol        ISSN: 0001-5938


  3 in total

1.  Time course of anti-SL-IV immunoglobulin G antibodies in patients with tuberculosis and tuberculosis-associated AIDS.

Authors:  N Martin-Casabona; T Gonzalez Fuente; F Papa; J Rosselló Urgell; R Vidal Plá; G Codina Grau; I Ruiz Camps
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

2.  A rapid, simple enzyme immunoassay for detection of antibody to individual epitopes in the serodiagnosis of tuberculosis.

Authors:  E Wilkins; G Bothamley; P Jackett
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-07       Impact factor: 3.267

3.  Production of monoclonal antibody to a phenolic glycolipid of Mycobacterium tuberculosis and its use in detection of the antigen in clinical isolates.

Authors:  S N Cho; J S Shin; M Daffe; Y Chong; S K Kim; J D Kim
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.